Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults

NCT02788188 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

NIH

Sponsor class

Conditions

Middle East Respiratory Syndrome Coronavirus

Interventions

BIOLOGICAL: SAB-301
OTHER: Normal (9%) Saline

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]